Showing results (1211-1220 of 1,523) with videos related to

Sort By:
Pageof 153
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2018
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating MutationsTony S Mok, Ying Cheng, Xiangdong Zhou, et al.
Cell Death Discovery|October 21, 2020
Gut microbiota patterns associated with somatostatin in patients undergoing pancreaticoduodenectomy: a prospective studyGuan-Qun Li, Tao Zhang, Wei-Guang Yang, et al.
Thoracic Cancer|July 12, 2022
Investigation on the incidence and risk factors of lung cancer among Chinese hospital employeesZi-Hao Chen, Zhi-Yong Chen, Jing Kang, et al.
Clinical Lung Cancer|June 20, 2025
A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203)Jia-Xin Lin, Qing Zhou, Hong-Hong Yan, et al.
BMJ Open|June 24, 2022
Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in ChinaHai-Yan Wang, Hong-Qiu Gu, Qi Zhou, et al.
British Journal of Cancer|December 23, 2016
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6Yi-Long Wu, Lecia V Sequist, Cheng-Ping Hu, et al.
Journal of Inflammation Research|March 14, 2022
LncRNA-miRNA-mRNA Network Analysis Reveals the Potential Biomarkers in Crohn's Disease Rats Treated with Herb-Partitioned MoxibustionXue-Jun Wang, Xiao-Ying Li, Xiao-Cong Guo, et al.
Annals of Translational Medicine|March 12, 2021
Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study, CTONG-0904): an open-label, randomized, phase III trialLi Zhang, Shun Lu, Ying Cheng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland ChinaYi-Long Wu, Wen-Zhao Zhong, Long-Yun Li, et al.
Clinical Lung Cancer|December 15, 2020
Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901)Xiang-Meng Li, Wen-Feng Li, Jun-Tao Lin, et al.
Pageof 153